Adrenomedullin (AM) is a multifunctional peptide with various physiological actions, including vasodilatation, a defense mechanism against microorganisms, the regulation of growth and the regulation of insulin and glucose. In this study, we measured the vitreous AM levels in patients with diabetes mellitus to determine its potential involvement in the pathogenesis of diabetic retinopathy (DR). We used an immunoradiometric assay to measure the vitreous AM concentrations in a total of 28 eyes: 13 with DR and 15 with macular holes (15 men and 13 women, 62.9 +/- 10.4 years old). The AM levels in the vitreous fluid of patients with DR (22.9 +/- 7.9 fmol/ml) were found to be significantly higher than the corresponding AM levels in patients with macular holes (4.7 +/- 1.1 fmol/ml) (p < 0.05). These results indicate that the increase in the vitreous AM is related to DR.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000068244 | DOI Listing |
Int Ophthalmol
January 2025
Department of Ophthalmology, The Second Hospital of Jilin University, #218 Ziqiang Street, Changchun, 130041, Jilin, China.
Purpose: The purpose of this study is to investigate the role of Secretogranin III (Scg3) in the pathogenesis of intraocular neovascular diseases and assess its potential as a therapeutic target for novel treatment strategies.
Methods: A literature review was conducted to examine the expression of Scg3 in intraocular neovascular diseases. We reviewed studies on the interaction of Scg3 with its homologous receptors and its effect on endothelial cell proliferation, migration, and vascular permeability-key processes involved in angiogenesis and neovascularization.
Telemed J E Health
December 2024
Division of Ophthalmology, Department of Surgery, UMass Chan-Lahey School of Medicine, Burlington, Massachusetts, USA.
To evaluate the effectiveness of a patient portal telehealth outreach program to return patients with diabetic retinopathy (DR) lost to follow-up (LTFU) for eye care. Patients with DR receiving intravitreal injection (IVI) therapy who were >90 days beyond recommended return were deemed LTFU. Outreach messages were sent via a patient portal, when available, or through the U.
View Article and Find Full Text PDFTher Adv Ophthalmol
January 2025
Department of Experimental Medicine, Ophthalmology Unit, University of Rome Tor Vergata, Via Montpellier 1, Rome, 00133, Italy.
Diabetic retinopathy and retinal vein occlusion represent two prevalent vision-threatening retinal diseases. Retinal laser therapy still plays an important role in treating these conditions, but its successful administration often requires referral to specialized centers and retina experts. It is, therefore, essential to develop a new treatment methodology that enables patients to benefit from the expertise of specialists from reference centers.
View Article and Find Full Text PDFJ Diabetes Res
January 2025
Department of Medical Statistics, King's College London, London, UK.
Diabetic nephropathy (DN) and diabetic retinopathy (DR) are serious complications of type 2 diabetes mellitus (T2DM). The reported estimates of prevalence and progression of DN and DR vary widely across studies. We undertook a systematic review and meta-analysis to determine the extent to which these variations in prevalence and progression of DN and DR may relate to different ethnic groups and socioeconomic status (SES).
View Article and Find Full Text PDFActa Med Philipp
December 2024
Department of Health Policy and Administration, College of Public Health, University of the Philippines Manila.
Objectives: This study aimed to describe the roles and responsibilities of doctors and nurses in managing conditions like hypertension and diabetes in rural areas.
Methods: This study employed a cross-sectional study design using the task analysis methodology. A self-administered questionnaire derived from a national health practice guideline was used.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!